Synergistic Combination of PD-1 and EGFR antibodies: a proposed phase I clinical trial utilizing nivolumab and cetuximab

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Feb 2016
Event2016 Multidisciplinary Head and Neck Cancer Symposium - Scottsdale, Arizona
Duration: Feb 1 2016 → …

Conference

Conference2016 Multidisciplinary Head and Neck Cancer Symposium
Period2/1/16 → …

Disciplines

  • Medicine and Health Sciences

Cite this